Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Medical Officer

Chief Executive Officer

Chief Financial Officer

General Counsel

Chief Operating Officer

Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB0139, an inhaled small molecule inhibitor of galectin-3 that is in Phase IIb clinical trial for the treatment of fibrotic lung diseases, such as idiopathic pulmonary fibrosis, a life-threatening progressive fibrotic disease of the lung; GB2064, a selective oral small molecule inhibitor of LOXL2 that is in Phase 2a clinical trial for the treatment of myelofibrosis; and GB1211, a selective oral galectin-3 inhibitor that is in Phase IIa for the treatment of cancer, as well as in Phase Ib/IIa for fibrosis. Galecto, Inc. was founded in 2011 and is headquartered in Copenhagen, Denmark.

Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other r...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2023-08-15	Premium	sold	Premium	Premium	Premium	-
2023-07-31	Premium	sold	Premium	Premium	Premium	-
2023-07-25	Premium	sold	Premium	Premium	Premium	-
2023-07-13	Premium	sold	Premium	Premium	Premium	-
2023-04-17	Premium	sold	Premium	Premium	Premium	-
2023-04-14	Premium	sold	Premium	Premium	Premium	-
2023-04-13	Premium	sold	Premium	Premium	Premium	-
2023-04-12	Premium	sold	Premium	Premium	Premium	-
2023-04-11	Premium	sold	Premium	Premium	Premium	-
2023-04-10	Premium	sold	Premium	Premium	Premium	-
2023-04-06	Premium	sold	Premium	Premium	Premium	-
2023-04-05	Premium	sold	Premium	Premium	Premium	-
2022-03-22	Premium	bought	Premium	Premium	Premium	Chief Medical Officer
2022-03-22	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2021-12-03	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2021-12-03	Premium	bought	Premium	Premium	Premium	General Counsel
2021-11-09	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2021-11-08	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2021-08-18	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2021-06-28	Premium	bought	Premium	Premium	Premium	Chief Medical Officer
2021-06-24	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2021-06-23	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2021-06-23	Premium	bought	Premium	Premium	Premium	General Counsel
2020-11-02	Premium	acquired	Premium	Premium	Premium	-
2020-11-02	Premium	acquired	Premium	Premium	Premium	-

GLTO - Galecto Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for GLTO